158 related articles for article (PubMed ID: 16281481)
1. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
Rudenko TE; Kutyrina IM; Shvetsov MIu
Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study.
Conrady AO; Rudomanov OG; Zaharov DV; Krutikov AN; Vahrameeva NV; Yakovleva OI; Alexeeva NP; Shlyakhto EV
Blood Press; 2004; 13(2):101-9. PubMed ID: 15182113
[TBL] [Abstract][Full Text] [Related]
7. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
Tomilina NA; Gendlin GE; Zhidkova DA; Tronina OA; Fedorova ND
Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
[TBL] [Abstract][Full Text] [Related]
8. [Left ventricular remodeling in association of arterial hypertension with diabetes mellitus type 2: correlation with gender and disease duration].
Karpov RS; Koshel'skaia OA
Ter Arkh; 2007; 79(1):32-8. PubMed ID: 17385461
[TBL] [Abstract][Full Text] [Related]
9. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
10. Association between wasted pressure effort and left ventricular hypertrophy in hypertension: influence of arterial wave reflection.
Hashimoto J; Nichols WW; O'Rourke MF; Imai Y
Am J Hypertens; 2008 Mar; 21(3):329-33. PubMed ID: 18202668
[TBL] [Abstract][Full Text] [Related]
11. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
[TBL] [Abstract][Full Text] [Related]
12. Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease.
Kunisek J; Zaputović L; Mavrić Z; Kunisek L; Bruketa-Markić I; Karlavaris R; Lukin-Eskinja K
Med Klin (Munich); 2008 Oct; 103(10):705-11. PubMed ID: 18936895
[TBL] [Abstract][Full Text] [Related]
13. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
Cortés R; Otero MR; Morillas P; Roselló-Lletí E; Grigorian L; Martínez-Dolz L; de Burgos FG; Calabuig JR; Soria F; Lozano T; Portolés M; Bertomeu V
Am J Hypertens; 2008 Jul; 21(7):820-5. PubMed ID: 18443568
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
15. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
16. [Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity].
Kazymov MS; Fishman BB; Veber VR; Fishman MB; Kopina MN; Kuprin PE
Ter Arkh; 2009; 81(4):73-5. PubMed ID: 19514427
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
Barrios V; Escobar C; Calderon A; Ribas L; Marti D; Asin E
Blood Press; 2008; 17(2):110-5. PubMed ID: 18568700
[TBL] [Abstract][Full Text] [Related]
18. [Comparative aspects of the structural and functional status of the myocardium in left-ventricular asymmetrical myocardial hypertrophy in patients with hypertension and cardiomyopathy].
Iurenev AP; D'iakonova EG; Tolstov AN; Dubov PB; Nesterova AL; Gerashchenko IuS
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):19-23. PubMed ID: 2969735
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial hypertrophy and coronary insufficiency as a cause of arrhythmia in patients with hypertension].
Israpilov MM; Gerashchenko IuS; Fofanova TV; Iurenev AP
Ter Arkh; 1999; 71(4):37-40. PubMed ID: 10358861
[TBL] [Abstract][Full Text] [Related]
20. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
